文献速递胃肠外科围术期管理与 ERAS

腹腔镜袖状胃切除术在BMI 30-34.9与<30的2型糖尿病患者中的疗效比较

Efficacy comparison of laparoscopic sleeve gastrectomy in type 2 diabetes patients with a BMI 30-34.9 kg/m2 versus BMI < 30 kg/m2.
PubMed 文献 · Surg Endosc · 2020-06-22

本研究纳入51例BMI<35的2型糖尿病患者,均行腹腔镜袖状胃切除术,按BMI分为23.23-29.97组和30.0-34.9组,比较术后3、6、12个月的减重和糖尿病指标。结果显示两组完全缓解率随时间升高,但BMI<30组12个月完全缓解率(44%)低于BMI 30-34.9组(88.5%)。

要点

  • LSG对BMI<35的T2DM患者短期安全有效。
  • BMI 30-34.9组12个月完全缓解率88.5%,高于BMI<30组的44%。
  • 糖尿病病程>15年者无一例完全缓解。

核心结论

  • LSG对BMI<35的T2DM患者短期安全有效。
  • BMI<30患者的T2DM完全缓解率远低于BMI 30-34.9患者。

研究设计与样本

  • 单中心研究,纳入51例BMI<35且成功行LSG的T2DM患者。
  • 按BMI分为A组(23.23-29.97 kg/m2)和B组(30.0-34.9 kg/m2),比较术后3、6、12个月减重和糖尿病特征。

主要发现

  • A组术后3、6、12个月T2DM完全缓解率分别为20%、36%、44%。
  • B组术后3、6、12个月T2DM完全缓解率分别为30.8%、61.5%、88.5%。
  • 病程>15年的患者无一例获得完全缓解。
  • BMI<30患者术后12个月,ABCD评分≤2者完全缓解率为15.4%,ABCD评分≥5者为100%。

临床怎么用

  • 对于BMI<35的T2DM患者,LSG可考虑作为治疗选择,但BMI<30者需预期完全缓解率较低。
  • 术前应评估糖尿病病程和ABCD评分,以预测LSG后T2DM完全缓解的可能性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Laparoscopic sleeve gastrectomy (LSG) is safe and effective in type 2 diabetes mellitus (T2DM) with body mass index (BMI) ≥ 35 kg/m2. However, the effect and safety of LSG in the treatment of T2DM patients with BMI less than 35 kg/m2, especially in patients with BMI less than 30 kg/m2, are still debatable. METHODS: A total of 51 T2DM patients with BMI less than 35 kg/m2 treated successfully with LSG were included in our study. All patients were divided into two groups for subgroup analysis, namely group A (BMI 23.23-29.97 kg/m2) and group B (BMI 30.0-34.9 kg/m2). The weight loss and diabetic characteristics of LSG in the two groups at 3 months, 6 months, and 12 months after operation were compared, respectively. RESULTS: In group A, the complete remission rates of T2DM were 20%, 36%, and 44% at 3, 6, and 12 months after operation, respectively. In group B, the complete remission rates of T2DM were 30.8%, 61.5%, and 88.5% at 3, 6, and 12 months after operation, respectively. Besides, none of the patients with a duration more than 15 years achieved complete remission. For T2DM patients with BMI < 30 kg/m2 at 12 months after LSG, the complete remission rate of T2DM was 15.4% in patients with ABCD scores ≤ 2, and the complete remission rate of T2DM was 100% in patients with ABCD scores ≥ 5. CONCLUSION: LSG is safe and effective for T2DM patients with BMI less than 35 kg/m2 in the short-term. However, the complete remission rate of T2DM in patients with BMI less than 30 kg/m2 is far from the diabetes patients with BMI at 30-34.9 kg/m2.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Wu D, Wang L, Jiang T, et al. Efficacy comparison of laparoscopic sleeve gastrectomy in type 2 diabetes patients with a BMI 30-34.9 kg/m2 versus BMI < 30 kg/m2. Surg Endosc. 2020. PMID: 32572628. doi:10.1007/s00464-020-07749-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。